MarginsXMarginsX
Home › Markets › Health Care › BFRI

Biofrontera Inc. (BFRI)

BFRI trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$0.5700
-18.58% on the day
Market cap
$10.2M
Nano cap
Revenue · 2025
$41.7M
+11.7% on 2024
Net income · 2025
-$10.5M
-25.3% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1858685/000149315226011625/0001493152-26-011625-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerBFRI on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited States
IPO year2021
SEC CIK0001858685
SEC industry codePharmaceutical Preparations
Incorporated inDE

Financials · 2025

LineValue
Revenue$41.7M
Net income-$10.5M
Operating income-$11.3M
Net margin-25.3%
Operating margin-27.2%
Revenue growth+11.7%
Cash$6.4M
Total assets$28.6M
P/E (computed)Net income was not positive
P/S (computed)0.2×

Warning signs

Cash runway
7.1 months
$4.7M cash at June 30, 2026
Share count, 1 year
+54.1%
2025-11-10 to 2026-11-11 · +1082.7% over 3 years
Going-concern doubt
Yes
10-Q filed November 13, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"Management believes that these conditions raise substantial doubt about the Company's ability to continue as a going concern within one year after the date these financial statements are issued."
10-Q 2026-11-13
Cash and burn$4.7M cash; operating cash flow -$2.0M a quarter.Report 2026-06-30
Shares outstanding17,949,000 (2026-11-11); 11,648,323 a year earlier; 1,517,628 three years earlier.Cover page 2026-11-11
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 months1 (8-K item 3.01)8-K 2026-01-07
Delisting25-NSE filed25-NSE 2026-10-30
AuditorCBIZ CPAs P.C., Morristown, New Jersey, United States; changed auditors 1 time in 24 months8-K 4.01 2025-04-18
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q2 2026
2026-06-30
$12.0M-$604K-$1.7M$4.7M$4.6M$46.2M10-Q 2026-08-13
Q1 2026
2026-03-31
$10.1M-$4.8M-$70K$6.3M$4.7M$43.2M10-Q 2026-05-14
Q4 2025
2025-12-31
$17.1M$5.6M-$2.4M$6.4M$4.6M$41.7M10-K 2026-03-19
Q3 2025
2025-09-30
$7.0M-$6.6M-$3.8M$3.4M$4.5M$37.2M10-Q 2025-11-12
Q2 2025
2025-06-30
$9.0M-$5.3M-$3.0M$7.2M$4.3M$39.2M10-Q 2026-08-13
Q1 2025
2025-03-31
$8.6M-$4.2M-$4.1M$1.8M$4.2M$38.0M10-Q 2026-05-14
Q4 2024
2024-12-31
$12.6M-$1.4M-$1.0M$5.9M$4.1M$37.3M10-K 2026-03-19
Q3 2024
2024-09-30
$9.0M-$5.7M-$1.2M$2.9MNo debt tags$35.4M10-Q 2025-11-12

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentS-12025-12-05
Latest annual report10-K/A2026-07-22
Latest quarterly / interim10-Q2026-11-13
Latest current report8-K2026-11-13
Latest proxyDEF 14A2026-04-30

Source: SEC EDGAR submissions feed, 368 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-15.5%
1 month-21.5%
3 months-44.4%
Year to date+22.8%
1 year-21.3%
From 52-week high-56.5%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
CLRBCellectar Biosciences Inc.$1.01-11.40%$10.1M
AEONAEON Biopharma Inc.$0.1407-8.04%$10.1M
HINDVyome Holdings Inc.$1.53-3.16%$10.7M
PTNPalatin Technologies Inc.$6.13-1.69%$10.9M
RADXRadiopharm Theranostics Limited$0.7676+1.00%$11.1M
LEXXLexaria Bioscience Corp.$4.41-0.68%$9.3M
ASBPAspire-Lakewood Holdings Inc.$8.06-5.29%$11.3M
GDTCCytoMed Therapeutics Limited$0.7739-6.68%$9.2M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier